Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
diabetes
3
×
life sciences
national blog main
3
×
cancer
infectious diseases
medical device
medical devices
merck
new york blog main
san diego blog main
san diego top stories
texas blog main
texas top stories
abeona therapeutics
academic research
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
aphelion capital
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
biolinq
biomedical
biomedsa
bioscience
biotech ipos
bolt biotherapeutics
boston blog main
boston top stories
boulder/denver blog main
What
new
3
×
plan
action
adds
advance
advantages
antonio
bar
based
bio
biolinq
biosensor
bringing
brings
businesses
city
develops
diabetes
draw
drug
expect
gamble
glucose
including
investors
juvenile
life
market
medco’s
million
monitoring
mover
patch
patients
payers
physicians
pricing
professionals
raised
research
Language
unset
Current search:
diabetes
×
new
×
" national blog main "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com
5 years ago
San Antonio Develops “Action Plan” to Draw Life Sciences Businesses